- 2022 - 2025 心血管病発症における血管壁ずり応力の意義の解明~新規内皮機能検査法を用いて
- 2022 - 2025 GPR40の腸管-肝臓連関に着目したリピドーム調節解明と糖脂質代謝改善機構の研究
- 2021 - 2024 3000人規模コホートによる新世代CGMを用いたIGTの心血管病発症機構の解明
- 2020 - 2023 低酸素誘導分子に着目した糖尿病性腎臓病機序解明-SGLT2阻害からのアプローチ
- 2019 - 2023 GPR40-腸内環境・細菌叢の相互作用による新規の脂質糖代謝異常の改善機構の探索
- 2016 - 2020 Exploration of the possible role of GPR40-incretin signals in improvement of fatty liver, glucose intolerance and dyslipidemia
- 2015 - 2018 Significance of simultaneous secretion of insulin and incretin regulated by SKIP molecule
- 2010 - 2016 Molecular Basis and Disorders of Control of Appetite and Fat Accumulation
- 2011 - 2012 Study of protective effects and transcriptional regulation by a novel fatty acid receptor in pancreatic beta cells: its implication in lipotoxicity and glucose intolerance
- 2008 - 2010 Elucidation of molecular mechanisms of insulin secretion disorders secondary to insulin resistance -study of GPR40-
- 2008 - 2009 A G protein-coupled receptor for fatty acids, GPR40 : a novel therapeutic target in treatment of adipotoxicity and glucose intolerance
- 2006 - 2007 G蛋白共役型脂肪酸受容体の糖尿病・メタボリック症候群における病態的意義
Show all